Afferenz Expands Sales Team to Address Rapid Growth and Industry Adoption of Its Software and Services Offerings.HERNDON, Va. -- Afferenz, a leading eClinical software and services company that addresses the information technology needs within the clinical trials environment, today announced the appointment of two members to its sales team. David Olson and Daniel Weddle, both veterans of the life sciences industry, join Afferenz following a strong year of global growth. In their roles as Directors of Business Development, each will continue to expand the Company's presence, cultivate client relationships, and grow sales. David Olson brings more than 30 years of experience in the pharmaceutical and life sciences industry to his role at Afferenz focusing on pharmaceutical, biotechnology, and medical device sponsors. Prior to joining the Company, Olson served as a senior executive and business development advisor to a number of firms in the clinical research, e-trial, ECG ECG electrocardiogram. ECG abbr. 1. electrocardiogram 2. electrocardiograph ECG Also called an electrocardiogram, it records the electrical activity of the heart. core lab, data provider, commercial, manufacturing, IT and regulatory functional areas of the life sciences sector. Olson founded The Mediscope Corporation, a firm providing life sciences strategic planning Strategic planning is an organization's process of defining its strategy, or direction, and making decisions on allocating its resources to pursue this strategy, including its capital and people. , corporate development, and investment research services to leading pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. . In addition to holding a number of key advisory roles on several assignments within the U.S Government, Olson held the positions of Secretary of Health for the City of Philadelphia, Executive Director of the Philadelphia Health Research Fund, Project Manager for the Hospital Association of Pennsylvania, and President of the Northern Division of the Albert Einstein Medical Center in Philadelphia. Olson holds a Bachelor's degree and a Master's in Hospital Administration from the University of Minnesota (body, education) University of Minnesota - The home of Gopher. http://umn.edu/. Address: Minneapolis, Minnesota, USA. . Daniel Weddle brings more than 20 years of experience in contract clinical development to Afferenz, with an extensive background in operations and business development in all phases of clinical development. His entrepreneurial spirit led him to found SiteAvail, Inc., a company offering paper conversion services, document storage, HIPAA (Health Insurance Portability & Accountability Act of 1996, Public Law 104-191) Also known as the "Kennedy-Kassebaum Act," this U.S. law protects employees' health insurance coverage when they change or lose their jobs (Title I) and provides standards for patient health, consultation services, and site communications tools and solutions for clinical development. Prior to SiteAvail, Weddle was the Senior Director of Business Development at LifeTree Technology, where he developed and executed a sales and marketing strategy focused on end-to-end process improvement in electronic data capture (EDC EDC See: Export Development Corp. ). Weddle also served in a variety of business development and sales and marketing roles with such companies as Averion, Inc., MDS MDS, n See temporomandibular pain-dysfunction syndrome. MDS 1 Maternal deprivation syndrome, see there 2 Myelodysplastic syndrome, see there Pharma, Pharmaceutical Research Plus, Inc., and Covance, and held clinical research positions at ICON Clinical Research and AAI AAI American Association of Immunologists. Pharma. Weddle holds Bachelor's degrees in Biology and Economics from the University of Hartford. "As a visionary company, moving from a hidden industry gem to one with a visible market position, we are pleased to have such an experienced tandem of professionals spearheading Afferenz' growth in 2006," said Ven Thangaraj, president of Afferenz. "The fact that Dan and Dave have deep industry expertise and proven business development skills will be instrumental in solidifying Afferenz' position in the clinical trials arena. Both gentlemen will play pivotal roles in bringing strategic focus to the Company, have an immediate impact on the Company's growth, and accelerate our market momentum." About Afferenz Afferenz is a leading eClinical software and services company that addresses the information technology needs within the clinical trials environment. Afferenz's unique portfolio combines information technology with process to accelerate clinical development through efficient trial and data management. Afferenz' Acceliant(TM) eClinical Suite is a comprehensive solution that offers users real-time efficiency, ease-of-use in trial design, unparalleled flexibility, regulatory compliance, and the unique ability to integrate multi-modal electronic data capture (EDC), Data Management (CDMS CDMS Cryogenic Dark Matter Search CDMS Certified Disability Management Specialist CDMS Certification of Disability Management Specialists CDMS Clinical Data Management System CDMS Climate Data Management System ), Trial Management (CTMS CTMS Clinical Trial Management System CTMS California Traditional Music Society CTMS Container Terminal Management System CTMS Clinical Trials Management Software CTMS Carrier Transmission Measuring System CTMS Constrained Tree Migration Scheme ), online image analysis and document management with traditional paper-based processes. Headquartered in Herndon, Virginia Herndon is a town in Fairfax County, Virginia, United States. The population was 21,655 at the 2000 census, which makes it the largest of three towns in the county.[1] History , and with development centers in Chennai, India, Afferenz boasts a global client roster that includes industry-leading contract research organizations (CROs), pharmaceutical, biotechnology, and medical device companies. Additional information on the company can be found on its website: www.afferenz.com. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion